Xenon Pharmaceuticals
XENE
$43.75
Share price
1.74%
Change (1 day)
8.89%
Change (1 year)
Categories
Xenon Pharmaceuticals (XENE) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $36.87 M
According to Xenon Pharmaceuticals's latest financial reports the company's total liabilities are $36.87 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Xenon Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $36.87 M | 12.95% |
| 2022-12-31 | $32.64 M | 48.58% |
| 2021-12-31 | $21.97 M | 23.23% |
| 2020-12-31 | $17.83 M | -68% |
| 2019-12-31 | $55.72 M | 191.22% |
| 2018-12-31 | $19.13 M | 87.82% |
| 2017-12-31 | $10.18 M | 184.08% |
| 2016-12-31 | $3.58 M | 23.02% |
| 2015-12-31 | $2.91 M | -80.09% |
| 2014-12-31 | $14.63 M | -51.8% |
| 2013-12-31 | $30.37 M | -40.08% |
| 2012-12-31 | $50.68 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | $0.82 B | 2,131.82% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | $0.26 B | 617.89% | 🇺🇸 USA |